Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01916317Phase 3Active Not Recruiting

Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer

Role: collaborator

NCT05818644Enrolling By Invitation

Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children

Role: collaborator

NCT03073993Not ApplicableCompleted

Nasogastric Versus Orogastric Route of Feeding in Preterm (<32 Weeks) Neonates

Role: lead

All 3 trials loaded